Sabby Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Sabby Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,321	Closed	-$972K	–	204
2021 Q4	$972K	Buy	4,321 +468	+12%	+$1.18K	0.14%	83
2021 Q3	$1.32M	Buy	3,853 +1,435	+59%	+$4.42K	0.18%	75
2021 Q2	$723K	Buy	2,418 +1,739	+256%	+$5.5K	0.1%	95
2021 Q1	$219K	Buy	+679	New	+$2.27K	0.04%	134
2016 Q4	–	Sell	-167	Closed	-$26K	–	336
2016 Q3	$26K	Hold	167	–	–	﹤0.01%	304
2016 Q2	$22K	Buy	+167	New	+$781	﹤0.01%	284
2016 Q1	–	Sell	-1,971	Closed	-$1.55M	–	362
2015 Q4	$1.55M	Hold	1,971	–	–	0.09%	151
2015 Q3	$1.67M	Hold	1,971	–	–	0.07%	181
2015 Q2	$2.16M	Sell	1,971 -678	-26%	-$8.7K	0.08%	159
2015 Q1	$3.7M	Buy	2,649 +784	+42%	+$12K	0.15%	100
2014 Q4	$3.15K	Buy	1,865 +877	+89%	+$12.8K	0.1%	94
2014 Q3	$1.33K	Buy	+988	New	+$11.8K	0.05%	140
2014 Q1	–	Sell	-508	Closed	-$702K	–	279
2013 Q4	$702K	Hold	508	–	–	0.04%	137
2013 Q3	$886K	Sell	508 -158	-24%	-$3.03K	0.06%	129
2013 Q2	$1.08M	Buy	+666	New	+$20.6K	0.07%	114

Other funds holding INFI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sabby Management's INFI Position: Q4 2021 in Review

Sabby Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 70,431 shares — an estimated $177K sold.

Sabby Management first reported a position in INFI in Q2 2013 and held it in 8 quarters. The position peaked at $1.71M in Q1 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

Sabby Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Sabby Management sold 70,431 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $177K.
Sabby Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
Sabby Management's Infinity Pharmaceuticals, Inc. position peaked at $1.71M in Q1 2021.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.